Use of mesenchymal stem cells in treating osteoarthritis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10780129
APP PUB NO 20180042966A1
SERIAL NO

15552410

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a use of hypoxia-cultured mesenchymal stem cells (MSCs) for manufacture of a cell graft for treating a musculoskeletal disorder, particularly osteoarthritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL YANG-MING UNIVERSITYTAIPEI CITY 112 TAIWAN (ROC)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hung, Shih-Chieh Taipei, TW 18 87

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 22, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 22, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00